Literature DB >> 31300965

Curcumin-Loaded Nanostructured Lipid Carrier Modified with Partially Hydrolyzed Ginsenoside.

Karthikeyan Selvaraj1, Bong-Kyu Yoo2.   

Abstract

The objective of the present study was to investigate the effect of partially hydrolyzed ginsenoside on the physicochemical properties and in vitro release of curcumin from phospholipid-based nanostructured lipid carrier (NLC). NLC formulas modified with partially hydrolyzed ginsenoside (NLC-PG) were prepared with different amounts of ginsenoside using the conventional hot-melt method. The average particle size of curcumin-loaded NLC-PG ranged from 150 to 200 nm, and polydispersity index was in the range of 0.101-0.177, indicating monodispersed particle size distribution. Optical microscopy showed no sedimentation or recrystallization of curcumin even at 10,000 μg/ml concentration as NLC-PG in distilled water, indicating significantly enhanced solubility. TEM image showed that the nanoparticles were monodispersed with a multilayered core/shell structure. X-ray diffraction and FTIR spectroscopy showed that curcumin was amorphous in the NLC-PG, and there was no interaction between curcumin and the excipients. In vitro release study using simulated gastric/intestinal fluid media revealed that the release rate (Jss) of curcumin from the NLC-PG increased as a function of the ginsenoside content in the lipid carrier. Moreover, the Jss of curcumin kept gradually increasing in the presence of lipase, whereas in the presence of viscozyme, it sharply increased until the ginsenoside content reached 9.09% and subsequently plateaued. Partially hydrolyzed ginsenoside increased the Jss of curcumin from curcumin-loaded NLC-PG and therefore may be useful for improving the bioavailability of curcumin.

Entities:  

Keywords:  curcumin; in vitro release; nanostructured lipid carrier; partially hydrolyzed ginsenoside

Mesh:

Substances:

Year:  2019        PMID: 31300965     DOI: 10.1208/s12249-019-1467-z

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  5 in total

1.  Preparation of Ergosterol-Loaded Nanostructured Lipid Carriers for Enhancing Oral Bioavailability and Antidiabetic Nephropathy Effects.

Authors:  Zhonghua Dong; Sajid Iqbal; Zhongxi Zhao
Journal:  AAPS PharmSciTech       Date:  2020-01-13       Impact factor: 3.246

2.  Long-term Survival, Tolerability, and Safety of First-Line Bevacizumab and FOLFIRI in Combination With Ginsenoside-Modified Nanostructured Lipid Carrier Containing Curcumin in Patients With Unresectable Metastatic Colorectal Cancer.

Authors:  Youngbae Jeon; Sun Jin Sym; Bong Kyu Yoo; Jeong-Heum Baek
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.077

3.  Design of Non-Haemolytic Nanoemulsions for Intravenous Administration of Hydrophobic APIs.

Authors:  Line Séguy; Anne-Claire Groo; Didier Goux; Didier Hennequin; Aurélie Malzert-Fréon
Journal:  Pharmaceutics       Date:  2020-11-25       Impact factor: 6.321

Review 4.  Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies.

Authors:  Hong Wang; Yu Zheng; Qiang Sun; Zhen Zhang; Mengnan Zhao; Cheng Peng; Sanjun Shi
Journal:  J Nanobiotechnology       Date:  2021-10-15       Impact factor: 10.435

Review 5.  Innovative Delivery Systems Loaded with Plant Bioactive Ingredients: Formulation Approaches and Applications.

Authors:  Anastasia Kyriakoudi; Eleni Spanidi; Ioannis Mourtzinos; Konstantinos Gardikis
Journal:  Plants (Basel)       Date:  2021-06-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.